Anti-Hepatitis B Virus Surface Antigen抗体(ab19979)

概述

  • 产品名称Anti-Hepatitis B Virus Surface Antigen抗体
    参阅全部 Hepatitis B Virus Surface Antigen 一抗
  • 描述
    兔多克隆抗体to乙型肝炎病毒Surface Antigen
  • 特异性Ab19979 reacts only with Hepatitis B surface antigen. Non-reactive with normal human serum.
  • 经测试应用适用于: ELISAmore details
  • 种属反应性
    Hepatitis B
  • 免疫原

    Hepatitis B surface antigen purified from human serum. Mixture of subtypes ad & ay.

性能

应用

Our Abpromise guarantee covers the use of ab19979 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
ELISA
  • 应用说明ELISA: Use at an assay dependent dilution.

    May be used in place of whole antiserum in almost any appropriate antibody based technique. Also suitable for conjugation purposes.

    Not tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • 靶标

    • 相关性Hepatitis B Virus (HBV) infection induces a disease state which manifests itself in a variety of ways, characterized by the extent of liver damage, inflammation and viral persistence. HBV infection is also associated with a 100 fold increased risk of hepatocellular carcinoma and currently infects over 250 million people worldwide. HBV has a partially double stranded 3.2 kilobase DNA genome which contains four open reading frames. One of these encodes a 154 amino acid protein called the HBx protein. HBx has been shown to be a transcriptional transactivator of both viral and cellular promoters. Lacking a DNA binding domain and nuclear localization signal, HBx is believed to exert transcriptional activity through protein protein interaction.
    • 细胞定位Virion membrane
    • 别名
      • Large envelope protein antibody
      • Large surface protein antibody
      • LHB antibody
      • Major surface antigen antibody

    Anti-Hepatitis B Virus Surface Antigen antibody (ab19979)参考文献

    This product has been referenced in:
    • Schliehe C  et al. Stable antigen is most effective for eliciting CD8+ T-cell responses after DNA vaccination and infection with recombinant vaccinia virus in vivo. J Virol 86:9782-93 (2012). Read more (PubMed: 22761378) »

    See 1 Publication for this product

    Product Wall

    There are currently no Abreviews or Questions for ab19979.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"